“a mild trend”

We found a decrease in high-mannose N-glycans and a mild trend to increase sialylations ( Figure S1 ), whereas the most consistent observation was an increase in fucosylated N-glycans ( Figure 1 D).

VPS15 (Vacuolar Protein Sorting 15) and VPS30 expression have not been much notably changed during the first two phases, but their expression tends to follow a mild trend of NSRGs.

Although the differences in TIM-3 expression on CD4 + and CD8 + T cells were not statistically significant, a mild trend toward higher expression was observed in non-survivors.

A recent meta-analysis [ 70 ], including 7 RCTs and 10 observational studies, reported that there was a mild trend toward improved survival in favor of SLED-treated patients with AKI (RR 0.86; 95% CI 0.74–1.00), although the evidence was weak because of a lack of significant differences when RCTs were considered separately.

There was a mild trend with age and attitudes, with older people tending to have a preference for longer life.

However, we observed numerically a mild trend favoring faecal calprotectin.

A mild trend was identified with better survival rates for the Magna group than for the Trifecta group, but no statistical difference was observed: 88.4 ± 3.4% and 77.1 ± 5.3%, respectively, at 5 years and 76.4 ± 7.1% and 73.6 ± 3.1%, respectively, at 8 years (p = 0.346).

Unexpectedly, there is even a mild trend towards an increase of the system mortality rate towards higher cutoff levels for annual admission volume.